MetLife, Inc. Website

MetLife, Inc.

NYSE-MET

Company Overview

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; and pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.

  • Name

    MetLife, Inc.

  • CEO

    Michel Abbas Khalaf

  • Website

    www.metlife.com

  • Sector

    Insurance

  • Year Founded

    1999

Company Statistics

Profile

  • Market Cap

    —

  • EV

    —

  • Shares Out

    —

  • Revenue

    —

  • Employees

    —

Margins

  • Gross

    —

  • EBITDA

    —

  • Operating

    —

  • Pre-Tax

    —

  • Net

    —

  • FCF

    —

Returns (5Yr Avg)

  • ROA

    —

  • ROTA

    —

  • ROE

    —

  • ROCE

    —

  • ROIC

    —

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    —

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    —

  • Net Debt

    —

  • Debt/Equity

    —

  • EBIT/Interest

    —

Growth (CAGR)

  • Rev 3Yr

    —

  • Rev 5Yr

    —

  • Rev 10Yr

    —

  • Dil EPS 3Yr

    —

  • Dil EPS 5Yr

    —

  • Dil EPS 10Yr

    —

  • Rev Fwd 2Yr

    —

  • EBITDA Fwd 2Yr

    —

  • EPS Fwd 2Yr

    —

  • EPS LT Growth Est

    —

Dividends

  • Yield

    —

  • Payout

    —

  • DPS

    —

  • DPS Growth 3Yr

    —

  • DPS Growth 5Yr

    —

  • DPS Growth 10Yr

    —

  • DPS Growth Fwd 2Yr

    —

Bulls Say

  • MetLife’s leading market positions in various international markets (particularly Latin America) could provide opportunities for higher growth.

  • MetLife's strategy has reduced exposure to riskier products like variable annuities with minimum guarantees and has increased investments in segments with steadier cash flows like the group benefits business, could allow the firm to consistently generate excessive returns.

  • MetLife is increasing its investment in its asset management business, which is capital-light and can significantly increase the overall return profile of the company.

Bears Say

  • MetLife offers many complex products that expose it to underwriting, investment, capital market, and interest-rate risks, making it hard to predict its risk and the likelihood of shareholder value destruction.

  • The advancement of AI in healthcare might significantly increase people’s life expectancy, leading to underpricing and destruction of shareholder value.

  • MetLife’s variable investment income (from alternative assets like real estate and private equity) is volatile and underperformed guidance from 2022-24. The 2025 volatility might lead to another year of underperformance.

Source: Morningstar Analysis - Nov 11, 2025

What's happening

Nov 6, 2025 - Dec 6, 2025

MetLife Inc Faces Mixed Results Amid Market Challenges

  • MetLife's third-quarter earnings report revealed adjusted earnings per share that exceeded expectations, but total revenues fell short.
  • Analyst sentiment turned cautious as BMO Capital reduced its price target for the company amidst ongoing financial sector challenges.
  • Despite some moments of optimism, overall trading conditions indicated underperformance relative to both historical benchmarks and broader market indices.

Over the past month, MetLife Inc. (MET) experienced a slight decline in stock performance with an overall movement of -0.0%. The company's third-quarter earnings report on November 6th presented a mixed picture; adjusted earnings per share were $2.37, surpassing expectations of $2.32, while total revenues were reported at $17.9 billion against an anticipated $18.8 billion. This disappointing revenue figure led to a significant drop in stock price by 5% on the same day.

Following these results, analyst actions negatively impacted MET's stock trajectory during this month. On November 18th, BMO Capital lowered its price target for MetLife from $84 to $81 while maintaining its rating on the shares; this adjustment reflected cautious sentiment regarding future growth prospects amid challenges within the financial sector.

Despite these setbacks, there were moments of optimism that provided some support for MET’s performance during this timeframe. Notably, discussions around market bottom callers resulted in an increase in MET’s price from $0.35 to $0.53 within one day on November 12th—this sparked interest among investors seeking recovery signals.

However, bearish trends persisted as investors reacted unfavorably to news surrounding risk management strategies implemented by MetLife itself related to a transaction involving Talcott Resolution Life Insurance Company aimed at reducing portfolio risk through variable annuity risk transfer transactions announced on December 2nd which contributed to another slight decline of -0.3%. Overall trading conditions indicated that MET had underperformed relative not only against its own historical benchmarks but also compared with broader indices such as the S&P 500 which returned +1.2% over the same period.

MetLife Inc underperformed the Financials (XLF) sector by -2.1%, reflecting ongoing struggles amidst fluctuating market conditions and investor sentiment focused heavily on recent financial disclosures and strategic corporate maneuvers.

NYSE:MET